MedTrace Logo

Effects of Omalizumab Compared to Non-Omalizumab Treatment in Asthma Patients

NCT02921178 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 124

Last updated 2016-10-03

No results posted yet for this study

Summary

The purpose of this study is effects of Omalizumab compared to non-Omalizumab treatment in the propensity-matched group on asthma exacerbation in asthma patients in Korea: a retrospective cohort in real world.

Omalizumab was approved 2007 in Korea and has been used in this center. We would like to collect and analyze the data and exacerbation outcomes of these patients on Omalizumab; no Korean real world data available.

Conditions

Interventions

OTHER

Omalizumab

comparision of using Omalizumab and non-Omalizumab treatment

Sponsors & Collaborators

  • Ajou University School of Medicine

    lead OTHER

Principal Investigators

  • Hae-sim Park, Ph.D. · Ajou University School of Medicine

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-09-30
Completion
2017-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02921178 on ClinicalTrials.gov